Pubblicazioni

IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Lawless, S; Sbianchi, G; Morris, C; Iacobelli, S; Bosman, P; Blaise, D; Remenyi, P; Byrne, Jl; Mayer, J; Apperley, J; Lund, J; Kobbe, G; Schaap, N; Isaksson, C; Lenhoff, S; Basak, G; Touzeau, C; Wilson, Kmo; Muniz, Sg; Scheid, C; Browne, P; Anagnostopoulos, A; Rambaldi, A; Jantunen, E; Kroger, N; Schonland, S; Yakoub-Agha, I; Garderet, L

Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP

2020 - EUROPEAN JOURNAL OF HAEMATOLOGY

Hayden, Patrick J; Iacobelli, Simona; PÃ©rez-SimÃ³n, JosÃ© Antonio; van Biezen, Anja; Minnema, Monique; Niittyvuopio, Riitta; SchÃ¶nland, Stefan; Meijer, Ellen; Blaise, Didier; Milpied, Noel; MÃ¡rquez-Malaver, Francisco J; Veelken, Joan Hendrik; Maertens, Johan; Michallet, Mauricette; Cammenga, JÃ¶rg; N'Guyen, Stephanie; Niederwieser, Dietger; Hunault-Berger, Mathilde; Bourhis, Jean Henri; Passweg, Jakob; Bermudez, Arancha; Chalandon, Yves; Yakoub-Agha, Ibrahim; Garderet, Laurent; KrÃ¶ger, Nicolaus